Press Release

GCC Heart Failure Treatment Devices Market to Reach USD 986 Million by 2030 Due to Alarming Heart Failure Rates in the Region

The GCC Heart Failure Treatment Devices Market size was valued at around USD  765 million in 2024 and is projected to reach USD  986 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.22% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. Heart failure & arrhythmia rates have been high in the GCC region. Factors such as obesity & smoking have been responsible for this. If not undergone ICD or CRT implantation surgeries, the patient’s condition becomes worse restricting them from continuing their day-to-day activities eventually causing death. Thereby, to enhance the patient’s way of living and life expectancy, the demand for heart failure treatment devices has been increasing in regional countries like Bahrain & Kuwait.

In addition to this, a significant proportion of men & women in the region have reported to be suffering from hypertension. Hypertension being the major factor behind heart failure has been contributing to the market growth of heart failure treatment devices by escalating the number of patients being admitted with heart failure in the region. Further, in the region, a heightened number of individuals have been suffering from the condition of diabetes. The risk & severity of heart failure increases with diabetes and device-based treatment becomes necessary for the patients, thereby positively influencing the market of heart failure treatment devices in the region.

Also, regional governments seeing the heart disease trends in their countries and boosting medical tourism have been significantly investing in the construction of newer hospitals as well as in the expansion of existing ones. These hospitals equipped with advanced cardiac care facilities would cater to the growing number of heart failure patients in the region, thereby creating an opportunistic demand for devices like ICDs & CRTs. Furthermore, AI integration, remote monitoring, miniaturization, MRI access, and other advancements in ICD & CRT devices have improved their reliability and efficiency in the treatment & management of heart failure. As a result, the demand & acceptance for these devices have been increasing in the region, further states the research report, “GCC Heart Failure Treatment Devices Market Analysis, 2025.”

GCC Heart Failure Treatment Devices Market Segmentation Analysis

Cardiac Resynchronization Therapy (CRT) to Dominate Regional Market

Based on product type, the market is further bifurcated into Implantable Cardioverter-Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT), and Others. CRT Devices held a significant market share of the overall market. Many individuals across the region have been facing symptoms such as new or worsening shortness of breath or trouble breathing, coughing, chest pain, and others due to heart failure. These tend to hinder their day-to-day life and thereby the need for CRT devices for managing these heart failure symptoms and enhancing their way of living, has increased.

Further, many international bodies like the American Heart Association and European Society of Cardiology have been advocating for using Cardiac Resynchronization Therapy (CRT) Devices for the treatment & management of heart failure. As the GCC nations highly follow international standards and guidelines, the healthcare providers in these countries have been actively incorporating CRT treatment in their practice. Eventually, the market for these devices has been expanding in the region.

The UAE Leads the GCC Heart Failure Treatment Devices Industry

The UAE commands a substantial share of the GCC Heart Failure Treatment Devices Market. This has been because of patients with severe heart failure in the country who are present in large numbers & require effective treatment in the form of ICDs & CRTs. Further, in the UAE, a large number of individuals are expected to develop obesity in the coming years due to less involvement in physical activities, consumption of fast food items, etc. This is expected to contribute to the cases of heart failure & hypertension in the country eventually accelerating the demand for various heart failure treatment devices.

Moreover, as there have been a limited number of donors in the country, heart transplantation rates have been low. The impella heart pumps and LVAD demand thereby have been witnessing a boost as they form a bridge to transplantation for the patients, safeguarding their lives until they receive a heart transplant. Hence, considering the aforementioned factors, the UAE Heart Failure Treatment Devices Market has been expanding.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Johnson & Johnson Services, Inc. (Abiomed), and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the region?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?